The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Glickman Mark A since year 2005.
The trader's CIK number is 1441461.
At the time of this reporting, Glickman Mark A is the Chief Commercial Officer of Aralez Pharmaceuticals Inc. .
(stock ticker symbol ARLZ).
See this page for all insider trading activities at Aralez Pharmaceuticals Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2018-03-19||ARLZ||Aralez Pharmaceuticals Inc.||Sale||5,725||1.70||9,732|
|2016-05-16||ARLZ||Aralez Pharmaceuticals Inc.||Buy||25,000||3.68||92,050|
|2014-11-20||AUXL||Auxilium Pharmaceuticals Inc||Sale||47,952||33.17||1,590,615|
|2014-11-20||AUXL||Auxilium Pharmaceuticals Inc||Option Ex||40,750||21.75||886,190|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Glickman Mark A (Chief Commercial Officer of Aralez Pharmaceuticals Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.